Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common stock, par value $0.00001 per share
-
Shares outstanding
-
52,942,731
-
Total 13F shares
-
39,912,275
-
Share change
-
+1,655,181
-
Total reported value
-
$1,312,717,295
-
Price per share
-
$32.89
-
Number of holders
-
80
-
Value change
-
+$51,997,940
-
Number of buys
-
47
-
Number of sells
-
26
Institutional Holders of PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP) as of Q1 2021
As of 31 Mar 2021 PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP) had 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 39,912,275 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, INTERWEST VENTURE MANAGEMENT CO, Euclidean Capital LLC, Avoro Capital Advisors LLC, BOXER CAPITAL, LLC, VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., VANGUARD GROUP INC, and ALKEON CAPITAL MANAGEMENT LLC.
This table shows 80 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.